Adding pericardial effusion to the limited echo assessment of COVID patients can add a lot to the prognostic evaluation. Eihab Ghantous All 530 patients (mean age 63.1 years; 62% men) included in the ...

Pericardial effusion can develop quickly or slowly over time. Dr. Haider said to diagnose it, he starts with analyzing a patient’s symptoms.

Two hundred nineteen patients underwent pericardiocentesis during the study period. The effusion was cancer-related in 43.8% of cases. Median survival was 59.6 weeks (95% CI, 24.3 to 94.8 weeks).